Clinical Trial Update: Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

View source ↗

Summary

This clinical trial update describes the Target ALS biomarker study investigating longitudinal biofluids, clinical measures, and at-home assessments in people w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease
• Movement Disorders
• Neurodegenerative Disease

Snippet

Sponsor: Target ALS Foundation, Inc. | Conditions: Amyotrophic Lateral Sclerosis, Movement Disorders | Status: RECRUITING